Showing 361-370 of 2501 results for "".
Pay for Performance: Understanding and Preparing for MIPS
https://practicalneurology.com/columns/practice-management/pay-for-performance-understanding-and-preparing-for-mips/30418/As a new reimbursement model is set to unveil, physicians will have a tight window to prepare their practices to begin reporting in 2017.Preferred Treatment: The Changing Economics of Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/preferred-treatment-the-changing-economics-of-multiple-sclerosis-care/30486/By deciding which drugs are “preferred,” insurance companies are reducing the practice of evidence-based medicine to a series of economic choices.Confronting the Clinical Challenges of Frontotemporal Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/confronting-the-clinical-challenges-of-frontotemporal-dementia/30848/A look at FTD's symptoms, pathophysiology, subtypes, as well as the latest from imaging studies.Filling the Gap in Pediatric Neurology
https://practicalneurology.com/diseases-diagnoses/child-neurology/filling-the-gap-in-pediatric-neurology/30265/The view from an area without pediatric neurologists.- Turf Wars: Reports From the Front Linehttps://practicalneurology.com/columns/practice-management/turf-wars-reports-from-the-front-line/31111/In the October 2007 issue of Practical Neurology, Associate Editor Zac Haughn explores the complex landscape of professional conflicts and collaborations within the field of neurology. The article delves into the "turf wars" that arise when neurologists compete with other specialists, such as pulmon
Depression and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/depression-and-multiple-sclerosis/30264/Addressing depression may improve care for patients with multiple sclerosis.Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/The Evolving Role of Neurologists Amid the Endovascular Revolution in Stroke Care
https://practicalneurology.com/diseases-diagnoses/stroke/the-evolving-role-of-neurologists-amid-the-endovascular-revolution-in-stroke-care/30391/New standards of care are shaping a brighter future in stroke treatment, but many challenges remain.Expert Opinion: Emerging Strategies for Rehabilitation of the Stroke Patient
https://practicalneurology.com/diseases-diagnoses/stroke/1109_07-php/30876/In the past few decades, new understanding about the plasticity of nervous system organization coupled with innovative techniques for physical therapy have provided new options for post-stroke rehabilitation.Mental Health and Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/mental-health-and-parkinsons-disease/30246/Assessing and addressing mental health in patients and care partners improves quality of life.